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Three different intercellular adhesion molecules 
(ICAMs) have been identified acting as ligand for 
counter-receptor leukocyte-function-associated an-
tigen-1 (LFA-1) (CDlla/CD18). We have recently 
shown that ICAM-1 (CD 54) is present on cultured 
human epidermal Langerhans cells but not on freshly 
isolated Langerhans cells, and that this molecule 
participates in the generation of an antigen-specific 
T-cell response. ICAM-2 (CD102) was not involved 
because this molecule is expressed by neither fresh 
nor cultured Langerhans cells. In this study, the 
presence of ICAM-3 (CD50) on Langerhans cells was 
examined. Flow cytofluorometric analysis demori-
strated that ICAM-3 is strongly displayed by fresh 
Langerhans cells, and daily determinations showed 
that the level of this trypsin-resistant molecule re-
mained nearly unchanged during in vit,'o culture for 
up to 4 d, indicating that Langerhans cells constitu-
tively express this molecule. Analysis of RNA ex-
I nteraction between the antigen/major histocompatibili ty complex displayed by the antigen-presenting cell (APC ) and the T-cell receptor induces signal transduction , resu lting in antigen-specific activation of the T cell . H owever, o ptimal T-cell stimul ation also requires antigen-independent co-
stimulation m ediated ,"a IJ1teraction between so-cal led adhesion 
m o lecules on APC and their ligands on T cells [1-3] . Epidermal 
Langerhans cells belong to the [;lIni ly of dendritic cells, which are 
specialized , powerful APC for the induction of T -cell responses 
[4 ,5] . Intercellular adhesion molecul e (I C AM-l) (CD54), leuko-
cyte-function-associated antigen (LFA)-3 (CD58), and E7/ EEl 
(CD80), absent on freshly isolated human Langerhans cells but 
clearly present on cultured Langerhans cells, have been docu-
m en ted to playa role in T - cell activation [6-9]. rCAM-2 (CDI02), 
a second ligand for LFA-1 (CD11 a/CD18), did no t participate 
because this molecule was not expressed by fi'eshly isolated Langer-
hans cells or cultured Langerhans cells [9] . R ecently, rCAM-3 
(CD50) was de fin ed as the third receptor for LFA-1, differing from 
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tracted from purified cultured Langerhans cells by 
means of reverse transcriptase-polymerase chain re-
action demonstrated the presence of mRNA specific 
for ICAM-3. Antigen-specific T-cell responses trig-
gered by Langerhans cells were dose-dependently 
inhibited by anti-ICAM-3 if the antibody was added 
within the first 16 hof T-cell stimulation. Simulta-
neous addition of anti-ICAM-1 and anti-ICAM-3 syn-
ergistically inhibited T-cell responses, although a 
total block was never achieved. Pretreatment of 
Langerhans cells with anti-ICAM-3 resulted in a re-
duced T-cell response, whereas pretreatment of T 
cells did not. Thl'se results suggest that ICAM-3 on 
Langerhans cells, like ICAM-1, is functionally in-
volved in the initiation of antigen-specific activation 
of T cells, but the expression of these two ICAMs on 
Langerhans cells is differently regulated. Key woyds: 
ICAM-1lantigen pl'eselltatioll. J Itwes t Dem,atol 104:995-
998, 1995 
ICAM-1 and ICAM-2 in cDNA and amino acid sequences and in 
cellular distribution [10-12]. Although the presence ofICAM-3 on 
Langerhan s ce LI s ill sit" has been dem onstrated [13], it is not yet 
clear whether ICAM-3 o n Langerhan s cells plays a significant role 
in the activation ofT cells. In tlus study, w e demonstrated t11at both 
freshly isolated Langerhans cells and cultured Langerhans cells 
exhibit a comparable strong expression of ICAM-3 and show that 
tlus molecule on Langerhans cells is fWlctional1y involved in the 
ilutiation phase of antigen-specific T - cell proliferation. 
MATER.lALS AND METHODS 
Antibodies and Reagents Five different anti-ICAM-3 monoclonal 
antibodies (MoA bs) were used in thj s study: hybridoma supernatants 
HP2I19, T P1 124, and T Pt125 (all /Tom F. Sanchez, Madrid [13]) and 
purified proteins of CBR.-I C3/ 1 (A.R. de Fougero lles [10]) and BRlC79 
(0.] . Anstee; In terna tional Blood Group R eference Laboratory, Bristol, UK 
[1 4]). All other primary and secondary antibodies have been described [9]. 
Cells were cultured in (scove's modified Dulbccco's medium (Gibco. 
Paisley, Sco tlaHd) supplemented with '10% pooled nom,,1 human serum and 
50 iJ.g/ m1 gentamicin. Ca /l dida albien/ls antigen was obtained from AR.TU 
Biochemicals (Lclystad, T he Netherlands). 
Isolation of Cells Langerl13ns cells were isolated as described in detail 
before [9.15]. In brief. a single epidermal cell suspension was obtained after 
trypsinization (0.25% trypsin , 30 min , 37°C) of normal human breast or 
abdominal skin . After discontinuous Ficoll-Metrizoate density gradient 
centri fugation , cells between densities of 1.070 and 1.052 g/cm' were 
collected . T his cell popula tion consisted of 50% to 80% CO l a + cell s. T cell s 
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Figure 1. Both fresh and cultured 
human Lallgerhans cells express 
ICAM-3. Langerhans-cell- enriched 
suspensions were double stained and 
gated for cell s positive for HLA-DR-
fluorescein isothiocyana te (green fluo-
rescence). Gated cells were analyzed 
fo r the presence of IC AM-l or ICAM-3 
(red fluorescence; shown in this fIgure). 
Langerhans cell s were tested directl y 
after isolation (day 0) or at indicated 
times after isolation. T he level of these 
ICA Ms at da y 4 (not shown) was iden-
tical to that at day 3. T hese data are 
representative of three independent ex-
periments. 
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were purified as described previous ly [9] . Peripheral blood cell s were 
subjected to Lymphoprep (Nycomed, Oslo, Norway) and discontinuous 
Perco ll (Pharmacia, Uppsala, Sweden) density gradient centrifugation, 
followed by E-rosettill g of the high-density cell s and plastic adherence. The 
population of rosetted nonadherent ceLls contained more than 93°/., CD3 + 
ce Ll s. Low-density periphera l blood cells that were plasti c adherent were 
used as a source of monocytes (more than 90% C OlA +) . 
Fluorescence-Activated Cell Sorter Analysis Cells were double 
stained by successive incubations with primary MoAb, phycoerythrin-conj u-
gated (red) goat anti-mouse Ig, and fluorescein-isothlocyanatc-coruugated 
(green) anti-human leukocyte antigen (l-ILA)-DR [9]. Fl uorescence intensity 
was detenllined by a FACStar (Becton Dickinson, Mountain View, CA). 
Reverse Transcriptase-Polymerase Chain Reaction (PCR) Langer-
han s-cell-enriched ce ll s were cultured overnight, centrifuged on a Nyco-
denz density (1.080 g/cm'; Nycomed) gradient, and purif Ied (almost 100'X,) 
by the so-called panning technique [7]. While the cel ls were still attached 
to the petri di sh, 0.5 ml Trizol (Gibco) was added and tota l RNA was 
isolated according to the manufacturer's protocol. RNA was reverse 
transcribed into cDNA using MLV-RT (Gibco) in a 20-ILI re"ction; 2 ILl was 
taken for each PCR amp Lifi ca tion. Trizol was also used to iso late the RNA 
from monocytes stimulated overnight with 10 ILg/ml Lipopolysaccharide . 
T he PCR mix contained 50 ng of each primer per 50 ILl , 250 ILM dNTP mix 
(Phamlacia) , 50 mM KCI , 10 mM T ris-HCI pH 8.1, ·1.5 mM MgClz' 
0.00 1% gela tin , and 1.25 units T ag polymerase (Gibco), and was covered 
with 20 ILl mineral oiL R eactions were performed in 50 ILl per well in 
microtest pla tes (Becton Dicki nson) in a PTC-IOO thermal cycler (MJ 
R esearch Inc, Watertown, MA) using the fo llowing program of 35 cycles: 
denaturation at 94°C for "I min, annealing at 55°C for 1 min, and cxtension 
at 72°C fo r 1 min . Twenty microliters of each reaction was loaded on 1.4% 
agarose gels in TBE buffer (0 .09 M T ris-borate; 0 .002 M ethylcnedia-
minetetraace ti c acid , pH 8.0) , and PC R. products were visu;lIi zed by 
ethidium bromide sta ining. T he primers used were as fo llows: IC AM-3 
sense primcr 5' -CGAGTTCTTGCACAGGAACA-3' (nt 1150-1169), 
ICAM-3 antisense primer 5'-CCTGAAGACGTACATTAAGGCC-3' (nt 
1513- 1534) , ICAM-l scnsc primer 5'-TAGCAGCCGCAGTCATA-
ATG-3' (nt 1517-1536), IC AM-1 antisense primer 5'-AGTCTTGCTCCT-
TCCTCTTGG-3' (nt 1880-1900) , LFA-OI sense primer 5'-CGGCCAAA-
GACATCATCC-3' (nt 912-929), and LFA-1 antisense primer 5'-
CATGTGCTGGTATCGAGGG-3' (nt 1360-1378). 
T-Cell Proliferation Assay T ce ll s (5 X 104/ well) with 2 X 10' 
-y-irrad iated (3000 rad) autologous cultured Langerhans cell s and 10 /Lg/ ml 
C n/lrlida albiea"s antigen were cultured in a 96-well round-bottomed 
microtiter plate for 6 d, the last 18 h in the presence of [JH]thymidine. 
Contro l culturcs were T ce ll s alone or T cell s with either antigen o r cul tured 
Langerhans ce ll s. Incorporation of the isotope was determined by liquid 
scintillation spectroscopy and expressed as mean cpm of tripli cate cultures :!: 
SO. Results were stati stically evaluated by the unpaired Student t test. 
RESULTS 
ICAM-3 Is Constitutively Expressed by Human Langerbans 
Cells Fresh Langerhans cells as well as Langerhans cells cultured 
for 1 , 2 , 3, or 4 d were subj ected to double fluorescence sta ining, 
u sing their b rig ht staining for J-ILA-DR for ide ntifi cation. AIl 
Langerh ans cells displayed a cl ear expression of ICAM-3 at a ll t im e 
points tested and showed e ither no kin e tics (CBR-IC3/1 and 
HP2/19) or a slight i.ncrease (TP1I24 and TPlI25) durin g culture 
T I-LE JOURNAL OF INVESTIGATI V E DEitMATOLOGY 
ICAM-3 (CB R-I C3/1) ICAM-3 (TP1/24) 
fluor esce nce 
(Fig 1). T h e latter two MoAbs recognize a different doma in on 
ICAM- 3 th an the form e r two MoAbs [16]. rCAM-3 was not 
present on HLA-DR-negative cells contaminating the Lan gerhans 
cell suspe n sion. T h e constitutive expressio n of rCAM-3 on Lange r-
hans cells contrasted w ith th e dyn amic expression of lCAM-1, 
w h ich is abse nt o n freshly isolate d Langerhans cells and markedly 
up-reg ulated upon culture (Fig 1). Because trypsin exposure is 
necessary to isolate Langerhans cells, the effect of this prote o lytic 
enzyme on ICAM- 3 was tested . ICAM-3 appeal"ed to b e fa irly 
resistant to trypsinization, whereas ICAM-l disappeared (n = 3; 
data not shown). R everse t ranscriptase-PCR analysis of RNA 
extracted from overni.ght c ultured Langerhan s cells showed a cl ear 
signal specific for ICAM- 3 Fig 2), confirm ing the expression of this 
molecule at t h e mRNA level. Further, Langerhans-ce ll-derived 
RNA containe d mRNA for ICAM-1 but lacked mRNA for LFA- l, 
which corre lates nicely with earlier obse"vations done by fluore s-
cence-activated cell sorter analysis [9]. 
ICAM-3 on Human Langerhans Cells Is Involved in T - Cell 
Activation To determine whethe r ICAM- 3 partic ipates in anti-
gen-specific T - cell activation trigge re d by Langerhans cells, we 
added MoAb against this molecul e to a co- c ulture of T ce ll s with 
Lange rhans cells and antigen to b lock the fun ction of ICAM-3. 
MoAbs again st ICAM- J and ICAM-2 were included as inhibitory 
and noninhibitory isotype-matched controls, respectively [9] . Anti-
ICAM-3 caused inhibition of the T-cell response, indicating that 
ICAM-3, like rCAM-1, is involved in this response (Fig 3) . 
A ddition of seria l dilutions of the MoAb reveal ed that th e inhibition 
was dose dependent (n 2; data not shown) . 
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Figure 2. ICAM-l- al1d ICAM-3-specific mRNA is expressed ill 
humal1 Lal1gerhal1s cells. Total RNA extrncted fi'om Langcrhans cell s 
derived from breast (Ifl/Ies 1-3) o r abdomcn of a dilrerent donor (fnll es 4-6) 
was subjected to reverse transcriptase-PC R., applying speciti c primers for 
IC AM-l, IC AM-3, or LFA- 1. I~A from monocytes (MO ; lall es 8-10) was 
ll sed as a pos itive control. Lfl/Ie 7, ., OO-kb marker; lall e J 1, PCR run in the 
presence of ICAM-3 primers but in the abscnce of cDNA. T hese resul ts nrc 
representative of four separate experiments using dill-c rcnt dOllors c:Jch 
time . cLC, cultured Langerhans, cell s. 
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I MoAb added to culture: I 
none ~~~~~~~~~;;;;;;~ ICAM-! (RR)!l; )gGl) ICAM-I (7F7; IgG2a) ICAM-2 (6DS; IgG!) ICAM-2 (IC2!2; IgG2a) 
ICAM-3 (IC311; 19G!) 
ICAM-3 (BRIC79; Is02a) 
ICAM-! and -3 (7F7 + BRIC) 
ICAM-! and -2 (7F7 + IC2!2) 
ICAM-3 WId -2 (BRIC + IC2I2) 
* 
* 
* 
* ~** 
controls: 
T cell, and C .• lb. (DO eLC) 
T cell, and eLC (DO C.alb.) 
only T cells 
* 
* 
~ 
L-__ ~ __ ~ __ ~ __ ~ __ ~ __ ~ 
12 !6 20 24 
c.p.m. (thousands) 
Figure 3_ ICAM-3 is involved in antigen-specific T-cell stim.ula-
tion by cultured Langerhans cells. T cells were stimulated with cul tured 
Langerhans cell s and Ca"dida albiea"s (c. alb.) antigen in the presence or 
absence of the indkated MoAbs (10 /-Lg/ ml). Data are representative of 
three separate experiments and m'e expressed as mean cpm ::!: SD of 
triplicate cultures. *p < 0.05; '* p < 0.05 as compared with the marked 
group (*). cLC, cu ltured Langerhans cells. 
Combination of MoAbs against ICAM-3 and ICAM-1 resulted in 
additive inhibiti on; however, a complete block of the T-cell 
response was never achieved (Fig 3). Preincubation of cultured 
Langerhans cell s with MoAb before co-culture revealed that anti-
ICAM-3 treatment produced inhibition 'It the level of Langerhans 
cells and not at the T-cell level (Fig 4). As shown in Fig 5 , 
anti-ICAM-3 exerted its iJlhibitory effect only if added within the 
first 16 h of culture, suggesting that rCAM-3 on Langerhans cells 
functions during an early phase ofT-cell activation. The same he ld 
true for ICAM-1 , which is in agreement with previous observations 
[9]. 
DISCUSSION 
We found thatlCAM-3 is clearly and constitutively displayed by 
Langerhans cells ill lIiil'o, extend ing a recent o bservation that 
showed the presence of rCAM-3 on human Langerhans cells ill sitll 
[13] . The reason why the two domains of ICAM-3 differ in their 
expression kinetics is not kJlown, but one can speculate that freshly 
isolated Langerhans cells and cultured Langerhans cells differently 
glycosylate this molecule affecting only one domain. The presence 
pretreatment: I 
eLC T cells 
none none 
IC3!1 none 
BRIC79 none 
ICAM-I none 
!gG contr. nonc 
Donc IC3! ! 
nODe BRIC79 
none ICAM-! 
none IgG eonlr. 
IC3! ! IC3!l 
BRIC79 BRIC79 
ICAM-I lCAM-l 
IgG contr. IgG eontr. 
!O 
* 
* 
* 
* 
* 
* 
15 20 25 
c .p.m. (thousands) 
Figure 4. Pretreatment of Langer hans cells with anti-ICAM-3 in-
hibits antigen-specific T-cell stimulation. T cell s, cultured Langerhans 
cell s (cLC), 01' both were preincubated with the indicated MoAbs (10 
/-Lg/ml), washed carefully, and used in the antigen-specific T-cell prolifer-
ation assay. R.esu lts are representative of two separate experiments and are 
expressed as mean cpm ::!: SD of triplicate cultures . ' p < 0.05. 
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(thousands) 
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Figure 5. ICAM-3 on Langerhans cells has a functional role in the 
initiation ofT-cell activation. Indicated MoAhs (10 /-Lg/ ml) were added 
to co-cultures ofT cells plus cultured Langerhans cells and Calldida albiram 
antigen at the start of the experiment (OpCII bars) or after 16 h (shad"d bars) 
or 44 h (solid bars) of culture. DOlled bar is conrrol co-culture without MoAb. 
T hese data are representative of two experiments and are expressed as mean 
cpm ::!: SD of triplicate cultures. ' p < 0.05. 
ofm.RNA for ICAM-3 in Langerhans-cell-derived RNA provided 
further proof for expression of this molecule by Langerhans cells . 
The presence of ICAM-I-specific and the absence of LFA-1-
specific 11'1RNA in Langerhans cells confirm earlier data at tile 
protein level and support the opinion that Langerhans cells do not 
express LFA-1 [9,17,18] . In this respect, it is interesting to note that 
Langerhans cells differ ma.rkedly from dendritic cells from the 
blood , lung, or tonsil as concerns their adhesion-molecule pheno-
type. Fresh Langerhans cells and Langerhans cells ill sitJl constitu-
tively express only ICAM-3, whereas ICAM-I, LFA-3 , and B71 
BB1 appear on Langerhans cells during culture [6-9] , reflecting a 
process that is generally referred to as maturation. Dendritic cells 
express aU these molecules, as well as ICAM-2 and LFA-1 [19-24]. 
It is conceivable that the state of differentiation andlor the micro-
environment determine which adhesion molecules are expressed by 
Langerhans cells and dendritic cells. One may speculate further that 
tile regulation of tlus adhesive makeup of Langerhans cells and 
dendritic cells is directly correlated to their functional properties at 
different sites (e.g., antigen presentation or migration) . 
Addition of anti-ICAM-3 to co- cultures of T cells and Langer-
hans cells, as well as pretreatment of Langerhans cells with this 
MoAb to interfere with the function of ICAM-3 on Langerhans 
cells, inhibited the T-cell proliferation, indicating that rCAM-3 on 
Langerhans cells is functionally involved in the specific T-cell 
response to soluble antigen. T he presence of anti-ICAM-3 MoAb 
during culture inhibited the T-cell response to a greater degree than 
pretreatment of Langerhans cells. Langerhans cells are probably 
able to re-express new ICAM-3 during the 6-d culture with T cells 
and, in the case of pretreatment, no interfering MoAbs were 
present, allowing the newly expressed ICAM-3 molecules to 
contribute to T-cell activation. Time-course studies revealed that 
ICAM-3 on Langerhans cells is functiona lly important during the 
ilutiation phase ofT -cell activation, as was demonstrated earlier for 
rCAM-1 and LFA-3 [9]. We were not able to block completely tile 
T-cell response with anti-ICAM-3. Even when MoAbs against 
ICAM-1 and ICAM-3 were applied simultaneously, no tota] block 
could be achieved, altllOugh some synergism was found. This may 
be explained by the fa ct that Langerhans cells are equipped with 
other adhesion molecules, such as LFA-3 and B7 IBBI, providing 
alternative pathways to interact with T cells. 
In concl usion, ICAM-3 on Langerhans cells participates in T-cell 
activation, probably (like ICAM-1) by faci litating cell-cell contact 
aJld delivering costimulatory signals to the T cell lIin LFA-1. In 
addition (and unlike rCAM-l), ICAM-3 itself is able to transduce 
signals across the plasma membrane \,25,26]; thus, binding of 
ICAM-3 to its ligand LFA-l on the T cell may stimulate tile 
Langerhans cells as well. As concerns freshly isolated Langerhans 
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cells or Langerhans cells in situ, ICAM-3 is the sole receptor for 
LFA-1. Concerning cultured Langerhans cells, however, it is not 
yet known which of the two ICAMs on cultured Langerhans cells 
is the predominant counter-structure for LFA-l on T cells. In tlus 
respect, it is interesting to note that avidity of the ICAMs is 
dependent on the conformational state ofLFA-l [27] and therefore 
is related to the state of activation of T cells. 
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